{
  "created_at": "2021-10-01T20:20:02.439Z",
  "title": "Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent",
  "url": "https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/",
  "author": "_Microft",
  "points": 206,
  "num_comments": 201,
  "_tags": [
    "story",
    "author__Microft",
    "story_28719928",
    "front_page"
  ],
  "objectID": "28719928",
  "original_created_at": "2021-10-01T15:45:48.000Z",
  "image": "https://cts.businesswire.com/ct/CT?id=bwnews&sty=20211001005189r1&sid=acqr8&distro=nx&lang=en",
  "localize": [
    {
      "locale": "ja",
      "title": "抗ウイルス剤のモルヌピラビルが入院・死亡のリスクを約50％減少させる"
    },
    {
      "locale": "zh",
      "title": "抗病毒药物莫努匹拉韦将住院/死亡的风险降低了约50%。"
    },
    {
      "locale": "zh-Hant",
      "title": "抗病毒藥物莫努匹拉韋將住院/死亡的風險降低了約50%。"
    }
  ],
  "source_updated_at": 1633686000966
}